Target intelligence / Profile preview

DNA methyltransferase 3A pseudogene 1 (DNMT3AP1)

Target: DNMT3AP1
Molecular classification: Other (pseudogene)

Overview

DNA methyltransferase 3A pseudogene 1 (DNMT3AP1) is annotated as a pseudogene, meaning it is a non-functional genetic element that resembles the DNA methyltransferase 3A (DNMT3A) gene but does not encode a functional protein product. As a pseudogene, DNMT3AP1 lacks known biological functions, disease roles, or therapeutic relevance. It should not be confused with DNA methyltransferase 3A (DNMT3A), which is a catalytically active enzyme responsible for de novo DNA methylation as part of epigenetic regulation. DNMT3AP1 itself is not a druggable target and has no established role in drug interaction, disease association, or patient selection.

Other names: DNMT3A pseudogene 1

Beyond the preview

Go deeper on DNA methyltransferase 3A pseudogene 1 (DNMT3AP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA methyltransferase 3A pseudogene 1 (DNMT3AP1).

Explore the full profile